Jefferies Group's LFCR Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 32,500 shares of Lifecore Biomedical, Inc. (LFCR) worth $120,900, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Jefferies Group has maintained this position in LFCR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 32,500 shares. Largest reduction occurred in Q2 2024, reducing 18,700 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Lifecore Biomedical (LFCR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Lifecore Biomedical (LFCR) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +32,500 | New Buy | 32,500 | $3.72 |
| Q2 2024 | -18,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | +1,000 | Add 5.65% | 18,700 | $5.31 |
| Q3 2023 | +17,700 | New Buy | 17,700 | $7.55 |
Jefferies Group's Lifecore Biomedical Investment FAQs
Jefferies Group first purchased Lifecore Biomedical, Inc. (LFCR) in Q3 2023, acquiring 17,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Lifecore Biomedical, Inc. (LFCR) for 5 quarters since Q3 2023.
Jefferies Group's largest addition to Lifecore Biomedical, Inc. (LFCR) was in Q1 2026, adding 32,500 shares worth $120,900.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 32,500 shares of Lifecore Biomedical, Inc. (LFCR), valued at approximately $120,900.
As of the Q1 2026 filing, Lifecore Biomedical, Inc. (LFCR) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Lifecore Biomedical, Inc. (LFCR) was 32,500 shares, as reported at the end of Q1 2026.